Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Vistica

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Blood|September 1, 1980
Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cellsD T Vistica
Biochimica Et Biophysica Acta|January 19, 1979
Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cellD T Vistica
Molecular and Cellular Endocrinology|January 1, 1979
Steroid receptors and steroid response in cultured L1210 murine leukemia cellsD S Salomon, D T Vistica
Research Communications in Chemical Pathology and Pharmacology|October 1, 1978
Enhancement of melphalan therapy with glutaminase:asparaginaseD T Vistica, A Rabon, M Rabinovitz
Science (New York, N.Y.)|November 30, 1979
Differential competition with cytotoxic agents: an approach to selectivity in cancer chemotherapyM Rabinowitz, Y Uehara, D T Vistica
Research Communications in Chemical Pathology and Pharmacology|January 1, 1979
Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cellsD T Vistica, A Rabon, M Rabinovitz
Cancer Letters|January 1, 1979
Amino acid conferred protection against melphalan interference with melphalan therapy by L-leucine, a competitive substrate for transportD T Vistica, A Rabon, M Rabinovitz
Cancer Letters|May 1, 1979
Effect of L-alpha-amino-gamma-guanidinobutyric acid on melphalan therapy of the L1210 murine leukemiaD T Vistica, A Rabon, M Rabinovitz
Cancer Letters|February 1, 1980
A comparative cytogenetic study of melphalan-sensitive and -resistant murine L1210 leukemia cellsB P Schuette, M Rabinovitz, D T Vistica
Cancer Treatment Reports|September 1, 1976
Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cellsD T Vistica, J N Toal, M Rabinovitz
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Blood|September 1, 1980
Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cellsD T Vistica
Biochimica Et Biophysica Acta|January 19, 1979
Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cellD T Vistica
Molecular and Cellular Endocrinology|January 1, 1979
Steroid receptors and steroid response in cultured L1210 murine leukemia cellsD S Salomon, D T Vistica
Research Communications in Chemical Pathology and Pharmacology|October 1, 1978
Enhancement of melphalan therapy with glutaminase:asparaginaseD T Vistica, A Rabon, M Rabinovitz
Science (New York, N.Y.)|November 30, 1979
Differential competition with cytotoxic agents: an approach to selectivity in cancer chemotherapyM Rabinowitz, Y Uehara, D T Vistica
Research Communications in Chemical Pathology and Pharmacology|January 1, 1979
Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cellsD T Vistica, A Rabon, M Rabinovitz
Cancer Letters|January 1, 1979
Amino acid conferred protection against melphalan interference with melphalan therapy by L-leucine, a competitive substrate for transportD T Vistica, A Rabon, M Rabinovitz
Cancer Letters|May 1, 1979
Effect of L-alpha-amino-gamma-guanidinobutyric acid on melphalan therapy of the L1210 murine leukemiaD T Vistica, A Rabon, M Rabinovitz
Cancer Letters|February 1, 1980
A comparative cytogenetic study of melphalan-sensitive and -resistant murine L1210 leukemia cellsB P Schuette, M Rabinovitz, D T Vistica
Cancer Treatment Reports|September 1, 1976
Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cellsD T Vistica, J N Toal, M Rabinovitz
Pageof 4